Mesoblast Ltd (MESO) income statement
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
$10.89−0.29 (-2.59%)
Close on Nov 20, 2026Market cap $1.41BP/E –Yield –
Mesoblast Ltd financial ratios
See a number that looks wrong?